China Lilang Limited (5LX) - Net Assets
Based on the latest financial reports, China Lilang Limited (5LX) has net assets worth €4.25 Billion EUR (≈ $4.97 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€6.67 Billion ≈ $7.80 Billion USD) and total liabilities (€2.43 Billion ≈ $2.84 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check China Lilang Limited tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €4.25 Billion |
| % of Total Assets | 63.64% |
| Annual Growth Rate | 4.44% |
| 5-Year Change | 10.99% |
| 10-Year Change | 39.3% |
| Growth Volatility | 2.53 |
China Lilang Limited - Net Assets Trend (2013–2024)
This chart illustrates how China Lilang Limited's net assets have evolved over time, based on quarterly financial data. See how many days can China Lilang Limited fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for China Lilang Limited (2013–2024)
The table below shows the annual net assets of China Lilang Limited from 2013 to 2024. For live valuation and market cap data, see China Lilang Limited market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €4.06 Billion ≈ $4.74 Billion |
+2.21% |
| 2023-12-31 | €3.97 Billion ≈ $4.64 Billion |
+4.90% |
| 2022-12-31 | €3.78 Billion ≈ $4.42 Billion |
+2.96% |
| 2021-12-31 | €3.67 Billion ≈ $4.29 Billion |
+0.54% |
| 2020-12-31 | €3.65 Billion ≈ $4.27 Billion |
+1.31% |
| 2019-12-31 | €3.61 Billion ≈ $4.22 Billion |
+6.07% |
| 2018-12-31 | €3.40 Billion ≈ $3.97 Billion |
+8.22% |
| 2017-12-31 | €3.14 Billion ≈ $3.67 Billion |
+4.32% |
| 2016-12-31 | €3.01 Billion ≈ $3.52 Billion |
+3.45% |
| 2015-12-31 | €2.91 Billion ≈ $3.40 Billion |
+7.91% |
| 2014-12-31 | €2.70 Billion ≈ $3.15 Billion |
+7.34% |
| 2013-12-31 | €2.51 Billion ≈ $2.94 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to China Lilang Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 51.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €3.61 Billion | 89.68% |
| Other Components | €415.36 Million | 10.32% |
| Total Equity | €4.03 Billion | 100.00% |
China Lilang Limited Competitors by Market Cap
The table below lists competitors of China Lilang Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aprogen Pharmaceuticals Inc
KO:003060
|
$303.27 Million |
|
Hubei Forbon Technology Co Ltd
SHE:300387
|
$303.28 Million |
|
Ratos AB (publ)
ST:RATO-A
|
$303.31 Million |
|
Bear Creek Mining Corporation
V:BCM
|
$303.35 Million |
|
KNEAT.COM INC.
F:FOBK
|
$303.17 Million |
|
STI Co. Ltd
KQ:039440
|
$303.11 Million |
|
National CineMedia Inc
NASDAQ:NCMI
|
$303.07 Million |
|
Zhejiang Canaan Technology Co Ltd
SHE:300412
|
$303.00 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in China Lilang Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,967,392,000 to 4,025,723,000, a change of 58,331,000 (1.5%).
- Net income of 460,802,000 contributed positively to equity growth.
- Dividend payments of 398,196,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €460.80 Million | +11.45% |
| Dividends Paid | €398.20 Million | -9.89% |
| Other Changes | €-4.28 Million | -0.11% |
| Total Change | €- | 1.47% |
Book Value vs Market Value Analysis
This analysis compares China Lilang Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.11x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €2.62 | €0.38 | x |
| 2018-12-31 | €2.84 | €0.38 | x |
| 2019-12-31 | €3.01 | €0.38 | x |
| 2020-12-31 | €3.05 | €0.38 | x |
| 2021-12-31 | €3.07 | €0.38 | x |
| 2022-12-31 | €3.16 | €0.38 | x |
| 2023-12-31 | €3.31 | €0.38 | x |
| 2024-12-31 | €3.36 | €0.38 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently China Lilang Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.45%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.62%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.70x
- Recent ROE (11.45%) is below the historical average (17.44%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 20.53% | 22.45% | 0.66x | 1.39x | €264.74 Million |
| 2014 | 20.57% | 22.81% | 0.59x | 1.53x | €285.12 Million |
| 2015 | 21.47% | 23.25% | 0.57x | 1.63x | €334.05 Million |
| 2016 | 17.93% | 22.39% | 0.57x | 1.41x | €238.71 Million |
| 2017 | 19.45% | 25.03% | 0.64x | 1.21x | €296.87 Million |
| 2018 | 22.09% | 23.71% | 0.72x | 1.30x | €411.21 Million |
| 2019 | 22.52% | 22.20% | 0.80x | 1.27x | €451.55 Million |
| 2020 | 15.25% | 20.79% | 0.53x | 1.37x | €191.89 Million |
| 2021 | 12.74% | 13.85% | 0.67x | 1.36x | €100.79 Million |
| 2022 | 11.85% | 14.52% | 0.56x | 1.45x | €69.84 Million |
| 2023 | 13.37% | 14.97% | 0.54x | 1.64x | €133.69 Million |
| 2024 | 11.45% | 12.62% | 0.53x | 1.70x | €58.23 Million |
Industry Comparison
This section compares China Lilang Limited's net assets metrics with peer companies in the Apparel Manufacturing industry.
Industry Context
- Industry: Apparel Manufacturing
- Average net assets among peers: $7,546,955,588
- Average return on equity (ROE) among peers: 10.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| China Lilang Limited (5LX) | €4.25 Billion | 20.53% | 0.57x | $303.18 Million |
| FUXING CHINA GRP SD 5 (3FU1) | $571.69 Million | 0.12% | 0.57x | $11.52 Million |
| China Dongxiang (Group) Co. Ltd (4C1) | $10.26 Billion | 3.07% | 0.14x | $229.98 Million |
| Ahlers AG (AAH) | $48.92 Million | -19.01% | 1.97x | $143.66K |
| Hugo Boss AG (BOSA) | $1.56 Billion | 16.02% | 1.39x | $2.45 Billion |
| Hugo Boss AG (BOSS) | $740.30 Million | 44.44% | 1.03x | $2.54 Billion |
| H+M HEN.+MAU.UNSP.ADR 1/5 (HMSA) | $46.21 Billion | 25.15% | 2.90x | $26.09 Billion |
| ERMENEGILDO ZEG.DL -0001 (JN0) | $982.89 Million | 7.84% | 1.88x | $2.94 Billion |
| Ming Le Sports AG (ML2) | $1.43 Million | 8.49% | 0.03x | $3.60K |
About China Lilang Limited
China Lilang Limited, together with its subsidiaries, manufactures and sells branded menswear and related accessories in the People's Republic of China. The company designs, sources, manufactures, and sells business and casual apparel for men under the LILANZ and LESS IS MORE brands. It also offers management, brand management, trading, transaction, and storage services. The company distributes i… Read more